Apertura and FAST Partner on Angelman Gene Therapy Innovation
Austin, Texas & New York, August 5, 2026 The Foundation for Angelman Syndrome Therapeutics (FAST) has announced a strategic...
Diabetic Retinopathy
Advertisement
AEYE Health Study Validates AI for Diabetic Eye Screening
New York, August 4, 2026 AEYE Health has announced the publication of a real-world clinical study in the British...
REGENXBIO Reports Positive Long-Term Gene Therapy Results
ROCKVILLE, Md., July 18, 2026 REGENXBIO Inc. has announced positive long-term clinical data for its investigational one-time gene therapy,...
iHealthScreen Wins FDA 510(k) for iPredict-DR Software
RICHMOND HILL, N.Y., July 8, 2026 iHealthScreen, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
REGENXBIO Doses First Patient in NAAVIGATE Gene Trial
ROCKVILLE, Md., June 29, 2026 REGENXBIO Inc. has reached a major milestone in the advancement of gene therapy for...
Advertisements
Lupin Wins FDA Approval for Ranluspec Biosimilar Eye Drug
Mumbai, India and Naples, Florida, June 5, 2026 Global pharmaceutical company Lupin Limited has secured a major regulatory milestone...
Nona Biosciences Appoints Josh Xiao as New CSO
CAMBRIDGE, Mass., May 6, 2026 Nona Biosciences, a global biotechnology company specializing in biotherapeutic discovery and AI-driven drug development...
Bayer to Acquire Perfuse Therapeutics in $2.45B Deal
BERLIN, Germany, and SAN FRANCISCO, Calif., May 6, 2026 Bayer has announced an agreement to fully acquire Perfuse Therapeutics...
Advertisement
